For: | Jiang QL, Wang CF, Tian YT, Huang H, Zhang SS, Zhao DB, Ma J, Yuan W, Sun YM, Che X, Zhang JW, Chu YM, Zhang YW, Chen YT. Body mass index does not affect the survival of pancreatic cancer patients. World J Gastroenterol 2017; 23(34): 6287-6293 [PMID: 28974895 DOI: 10.3748/wjg.v23.i34.6287] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i34/6287.htm |
Number | Citing Articles |
1 |
Jing Li, Haiyan Zhang, Hongda Zhu, Zhu Dai. 25-hydroxyvitamin D concentration is positively associated with overall survival in advanced pancreatic cancer: A systematic review and meta-analysis. Nutrition Research 2023; 117: 73 doi: 10.1016/j.nutres.2023.07.001
|
2 |
Aysegul Sakin, Suleyman Sahin, Muhammed Mustafa atci, Nurgul Yasar, Cumhur Demir, Caglayan Geredeli, Abdullah Sakin, Sener Cihan. The Effect of Body Mass Index on Treatment Outcomes in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Platinum-Based Therapy. Nutrition and Cancer 2021; 73(8): 1411 doi: 10.1080/01635581.2020.1801774
|
3 |
Simcha Weissman, Kazuki Takakura, Guido Eibl, Stephen J. Pandol, Masayuki Saruta. The Diverse Involvement of Cigarette Smoking in Pancreatic Cancer Development and Prognosis. Pancreas 2020; 49(5): 612 doi: 10.1097/MPA.0000000000001550
|
4 |
Konstantin Schlick, Teresa Magnes, Lukas Ratzinger, Bernhard Jaud, Lukas Weiss, Thomas Melchardt, Richard Greil, Alexander Egle, Aamir Ahmad. Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters. PLOS ONE 2018; 13(11): e0206688 doi: 10.1371/journal.pone.0206688
|
5 |
Andrew A. Gumbs, Manana Gogol, Gaya Spolverato, Hebatallah Taher, Elie K. Chouillard. Systematic Review of the Integrative Medicine Recommendations for Patients with Pancreatic Cancer. Surgeries 2021; 2(2): 216 doi: 10.3390/surgeries2020022
|
6 |
Ningzhen Fu, Yu Jiang, Kai Qin, Hao Chen, Xiaxing Deng, Baiyong Shen. Higher body mass index indicated better overall survival in pancreatic ductal adenocarcinoma patients: a real-world study of 2010 patients. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-09056-0
|
7 |
Konstantin Schlick, Teresa Magnes, Florian Huemer, Lukas Ratzinger, Lukas Weiss, Martin Pichler, Thomas Melchardt, Richard Greil, Alexander Egle. C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients. Journal of Clinical Medicine 2019; 8(11): 1791 doi: 10.3390/jcm8111791
|
8 |
Bin Zhou, Dong Wu, Han Liu, Lu-tao Du, Yun-shan Wang, Jian-wei Xu, Fa-bo Qiu, San-yuan Hu, Han-xiang Zhan. Obesity and pancreatic cancer: An update of epidemiological evidence and molecular mechanisms. Pancreatology 2019; 19(7): 941 doi: 10.1016/j.pan.2019.08.008
|